Regulating myogenic differentiation of mesenchymal stem cells using thermosensitive hydrogels

Acta Biomaterialia

Volumn 26, Issue , 2015, Pages 23-33

  Xu, Yanyi ^a   Li, Zhenqing ^a   Li, Xiaofei ^a   Fan, Zhaobo ^a   Liu, Zhenguo ^b   Xie, Xiaoyun ^c   Guan, Jianjun ^a,c  

^a The Ohio State University   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c TONGJI UNIVERSITY   (China)

Author keywords

Elastic expansion modulus; Mesenchymal stem cells; Myogenic differentiation; Thermosensitive hydrogels

Indexed keywords

ACRYLIC MONOMERS; AMIDES; CELL CULTURE; ELASTIC MODULI; EXPANSION; FLOWCHARTING; GENE EXPRESSION; MUSCLE; OLIGOMERS; STEM CELLS; STRUCTURE (COMPOSITION);

ELASTIC EXPANSION; ELASTIC EXPANSION MODULUS; EXPANSION MODULUS; INJECTABLE HYDROGELS; ISCHEMIC LIMBS; MESENCHYMAL STEM CELL; MYOGENIC DIFFERENTIATIONS; STEM CELL THERAPY; STEM-CELL; THERMO-SENSITIVE HYDROGEL;

HYDROGELS;

ACRYLIC ACID; POLY(N ISOPROPYLACRYLAMIDE); HYDROGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; HEAT SENSITIVITY; HYDROGEL; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNTHESIS; WATER CONTENT; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; MECHANOTRANSDUCTION; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; SKELETAL MUSCLE CELL; TEMPERATURE; TISSUE ENGINEERING; YOUNG MODULUS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ELASTIC MODULUS; HYDROGELS; MECHANOTRANSDUCTION, CELLULAR; MESENCHYMAL STROMAL CELLS; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; RATS; TEMPERATURE; TISSUE ENGINEERING;

EID: 84942297353     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.08.010     Document Type: Article

References (59)

1. N.K. Gupta, E.J. Armstrong, and S.A. Parikh The current state of stem cell therapy for peripheral artery disease Curr. Cardiol. Rep. 16 2014 447
2. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes, and et al. Inter-society consensus for the management of peripheral arterial disease Int. Angiol. 26 2007 81 157
3. C. Alev, M. Ii, and T. Asahara Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases Antioxid. Redox Signal. 15 2011 949 965
4. E. Benoit, T.F. O'Donnell, and A.N. Patel Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review Cell Transplant. 22 2013 545 562
5. C.A. Hart, J. Tsui, A. Khanna, D.J. Abraham, and D.M. Baker Stem cells of the lower limb: their role and potential in management of critical limb ischemia Exp. Biol. Med. (Maywood, NJ) 238 2013 1118 1126
6. C. Jadlowiec, R.A. Brenes, X. Li, W. Lv, C.D. Protack, M.J. Collins, and et al. Stem cell therapy for critical limb ischemia: what can we learn from cell therapy for chronic wounds? Vascular 20 2012 284 289
7. A. Liew, and T. O'Brien Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia Stem Cell Res. Ther. 3 2012 28
8. Z. Raval, and D.W. Losordo Cell therapy of peripheral arterial disease: from experimental findings to clinical trials Circ. Res. 112 2013 1288 1302
9. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, I. Gillespie, and et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making J. Vasc. Surg. 51 2010 52s 68s
10. M.S. Conte Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia J. Vasc. Surg. 51 2010 69S 75S
11. S. Shintani, T. Murohara, H. Ikeda, T. Ueno, K. Sasaki, J. Duan, and et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation Circulation 103 2001 897 903
12. E. Tateishi-Yuyama, H. Matsubara, T. Murohara, U. Ikeda, S. Shintani, H. Masaki, and et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial Lancet 360 2002 427 435
13. P. Huang, S. Li, M. Han, Z. Xiao, R. Yang, and Z.C. Han Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes Diabetes Care 28 2005 2155 2160
14. A. Ozturk, Y. Kucukardali, F. Tangi, A. Erikci, G. Uzun, C. Bashekim, and et al. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia J. Diabetes Complications 26 2012 29 33
15. D.W. Losordo, M.R. Kibbe, F. Mendelsohn, W. Marston, V.R. Driver, M. Sharafuddin, and et al. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia Circ. Cardiovasc. Interv. 5 2012 821 830
16. E. Benoit, T.F. O'Donnell Jr., M.D. Iafrati, E. Asher, D.F. Bandyk, J.W. Hallett, and et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design J. Transl. Med. 9 2011 165
17. L. Mohammadzadeh, S.H. Samedanifard, A. Keshavarzi, K. Alimoghaddam, B. Larijani, A. Ghavamzadeh, and et al. Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia Exp. Clin. Endocrinol. Diabetes 121 2013 48 53
18. T. Iwase, N. Nagaya, T. Fujii, T. Itoh, S. Murakami, T. Matsumoto, and et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia Cardiovasc. Res. 66 2005 543 551
19. C. Altaner, V. Altanerova, M. Cihova, L. Hunakova, K. Kaiserova, A. Klepanec, and et al. Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells PLoS ONE 8 2013 e73722
20. D. Lu, B. Chen, Z. Liang, W. Deng, Y. Jiang, S. Li, and et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial Diabetes Res. Clin. Pract. 92 2011 26 36
21. J. Yan, G. Tie, T.Y. Xu, K. Cecchini, and L.M. Messina Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy Stem Cell Rev. 9 2013 360 372
22. P.K. Gupta, A. Chullikana, R. Parakh, S. Desai, A. Das, S. Gottipamula, and et al. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia J. Transl. Med. 11 2013 143
23. R.L. Bartel, E. Booth, C. Cramer, K. Ledford, S. Watling, and F. Zeigler From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T Stem Cell Rev. 9 2013 373 383
24. B.J. Capoccia, D.L. Robson, K.D. Levac, D.J. Maxwell, S.A. Hohm, M.J. Neelamkavil, and et al. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity Blood 113 2009 5340 5351
25. E.C. Perin, G. Silva, A. Gahremanpour, J. Canales, Y. Zheng, M.G. Cabreira-Hansen, and et al. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia Catheter. Cardiovasc. Interv. 78 2011 1060 1067
26. A. Miranville, C. Heeschen, C. Sengenes, C.A. Curat, R. Busse, and A. Bouloumie Improvement of postnatal neovascularization by human adipose tissue-derived stem cells Circulation 110 2004 349 355
27. T. Murohara Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis J. Cardiol. 53 2009 155 163
28. K. Kondo, S. Shintani, R. Shibata, H. Murakami, R. Murakami, M. Imaizumi, and et al. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis Arterioscler. Thromb. Vasc. Biol. 29 2009 61 66
29. G. Marino, M. Moraci, E. Armenia, C. Orabona, R. Sergio, G. De Sena, and et al. Therapy with autologous adipose-derived regenerative cells for the care of chronic ulcer of lower limbs in patients with peripheral arterial disease J. Surg. Res. 185 2013 36 44
30. A.J. Rufaihah, N.F. Huang, S. Jame, J.C. Lee, H.N. Nguyen, B. Byers, and et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease Arterioscler. Thromb. Vasc. Biol. 31 2011 e72 e79
31. Q. Lian, Y. Zhang, J. Zhang, H.K. Zhang, X. Wu, Y. Zhang, and et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice Circulation 121 2010 1113 1123
32. Y. Li, W. Liu, F. Liu, Y. Zeng, S. Zuo, S. Feng, and et al. Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemia Proc. Natl. Acad. Sci. U.S.A. 111 2014 13511 13516
33. L. Leroux, B. Descamps, N.F. Tojais, B. Seguy, P. Oses, C. Moreau, and et al. Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway Mol. Ther. 18 2010 1545 1552
34. C. Borselli, H. Storrie, F. Benesch-Lee, D. Shvartsman, C. Cezar, J.W. Lichtman, and et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors Proc. Natl. Acad. Sci. U.S.A. 107 2010 3287 3292
35. D.W. Hammers, A. Sarathy, C.B. Pham, C.T. Drinnan, R.P. Farrar, and L.J. Suggs Controlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion Biotechnol. Bioeng. 109 2012 1051 1059
36. M. Juhas, and N. Bursac Engineering skeletal muscle repair Curr. Opin. Biotechnol. 24 2013 880 886
37. D. Kuraitis, D. Ebadi, P. Zhang, E. Rizzuto, B. Vulesevic, D.T. Padavan, and et al. Injected matrix stimulates myogenesis and regeneration of mouse skeletal muscle after ischaemic injury Eur. Cells Mater. 24 2012 175 195 (discussion 95-6)
38. D. Shvartsman, H. Storrie-White, K. Lee, C. Kearney, Y. Brudno, N. Ho, and et al. Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling Mol. Ther. 22 2014 1243 1253
39. W. Bian, M. Juhas, T.W. Pfeiler, and N. Bursac Local tissue geometry determines contractile force generation of engineered muscle networks Tissue Eng. Part A 18 2012 957 967
40. V. Desiderio, F. De Francesco, C. Schiraldi, A. De Rosa, A. La Gatta, F. Paino, and et al. Human Ng2+ adipose stem cells loaded in vivo on a new crosslinked hyaluronic acid-Lys scaffold fabricate a skeletal muscle tissue J. Cell. Physiol. 228 2013 1762 1773
41. A.S. Salimath, and A.J. Garcia Biofunctional hydrogels for skeletal muscle constructs J. Tissue Eng. Regen. Med. 2014
42. A.J. Engler, S. Sen, H.L. Sweeney, and D.E. Discher Matrix elasticity directs stem cell lineage specification Cell 126 2006 677 689
43. L. Jongpaiboonkit, W.J. King, G.E. Lyons, A.L. Paguirigan, J.W. Warrick, D.J. Beebe, and et al. An adaptable hydrogel array format for 3-dimensional cell culture and analysis Biomaterials 29 2008 3346 3356
44. T.P. Kraehenbuehl, P. Zammaretti, A.J. Van der Vlies, R.G. Schoenmakers, M.P. Lutolf, M.E. Jaconi, and et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel Biomaterials 29 2008 2757 2766
45. S.J. Bryant, T.T. Chowdhury, D.A. Lee, D.L. Bader, and K.S. Anseth Crosslinking density influences chondrocyte metabolism in dynamically loaded photocrosslinked poly(ethylene glycol) hydrogels Ann. Biomed. Eng. 32 2004 407 417
46. Z. Li, F. Wang, S. Roy, C.K. Sen, and J. Guan Injectable, highly flexible, and thermosensitive hydrogels capable of delivering superoxide dismutase Biomacromolecules 10 2009 3306 3316
47. J. Guan, Y. Hong, Z. Ma, and W.R. Wagner Protein-reactive, thermoresponsive copolymers with high flexibility and biodegradability Biomacromolecules 9 2008 1283 1292
48. M. Moller, R. Kange, and J.L. Hedrick Sn(OTf)(2) and Sc(OTf)(3): efficient and versatile catalysts for the controlled polymerization of lactones J. Polym. Sci. Polym. Chem. 38 2000 2067 2074
49. K.L. Fujimoto, Z. Ma, D.M. Nelson, R. Hashizume, J. Guan, K. Tobita, and et al. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium Biomaterials 30 2009 4357 4368
50. F. Wang, Z.Q. Li, M. Khan, K. Tamama, P. Kuppusamy, W.R. Wagner, and et al. Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers Acta Biomater. 6 2010 1978 1991
51. J. Guan, F. Wang, Z. Li, J. Chen, X. Guo, J. Liao, and et al. The stimulation of the cardiac differentiation of mesenchymal stem cells in tissue constructs that mimic myocardium structure and biomechanics Biomaterials 32 2011 5568 5580
52. Y. Xu, S. Patnaik, X. Guo, Z. Li, W. Lo, R. Butler, and et al. Cardiac differentiation of cardiosphere-derived cells in scaffolds mimicking morphology of the cardiac extracellular matrix Acta Biomater. 10 2014 3449 3462
53. J.A. Burdick, and G. Vunjak-Novakovic Engineered microenvironments for controlled stem cell differentiation Tissue Eng. Part A. 15 2009 205 219
54. D.E. Discher, L. Sweeney, S. Sen, and A. Engler Matrix elasticity directs stem cell lineage specification Biophys. J. 2007 32a-a
55. Z.M.O. Rzaev, S. Dincer, and E. Piskin Functional copolymers of N-isopropylacrylamide for bioengineering applications Prog. Polym. Sci. 32 2007 534 595
56. Z. Ma, D.M. Nelson, Y. Hong, and W.R. Wagner Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability Biomacromolecules 11 2010 1873 1881
57. I. Noda, P.R. Green, M.M. Satkowski, and L.A. Schechtman Preparation and properties of a novel class of polyhydroxyalkanoate copolymers Biomacromolecules 6 2005 580 586
58. Y.S. Pek, A.C. Wan, and J.Y. Ying The effect of matrix stiffness on mesenchymal stem cell differentiation in a 3D thixotropic gel Biomaterials 31 2010 385 391
59. N. Huebsch, P.R. Arany, A.S. Mao, D. Shvartsman, O.A. Ali, S.A. Bencherif, and et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate Nat. Mater. 9 2010 518 526